Ultrasep ES Pharm-Spezial RP8 is a silica-based HPLC column with a specialty C8 bonded phase, developed for pharmaceutical applications requiring balanced hydrophobicity and enhanced robustness. Compared to conventional C18 phases, the shorter C8 chains provide faster elution and improved peak resolution for moderately hydrophobic analytes, making it particularly suitable for time-critical and routine quality control applications.
The “Spezial” bonding chemistry ensures improved phase stability and long operational lifetime, even under challenging method conditions. Pharm-Spezial RP8 offers reliable reproducibility, sharp peak shapes, and consistent results for pharmaceutical separations.
Ultrasep ES Pharm-Spezial RP8 delivers balanced hydrophobicity and enhanced robustness – the dependable choice for pharmaceutical laboratories seeking reliable and efficient HPLC separations.
Silica-based stationary phase with specialty C8 bonded chemistry
Balanced hydrophobic retention for faster separations than C18
Improved resolution for moderately hydrophobic compounds
Specialty bonding for enhanced stability and reproducibility
Available particle size: 5 µm
Pharmaceutical quality control and stability testing
Analysis of moderately hydrophobic drugs and metabolites
Faster separations in routine pharmaceutical workflows
Method development requiring robust and reproducible C8 selectivity
| Particle Size |
|
|---|---|
| Pore Size | 100 Å |
| Particle Type | |
| Separation Mode | |
| USP Code | |
| pH Range | 2 - 8 |
| Phase | Material Number |
|---|---|
| Ultrasep ES Pharm-Spezial RP8, 5 µm | u15.ps8. |